RAPID MICRO BIOSYSTEMS INC RPID
CLASS A COM · Common Stock · CUSIP 75340L104
- SectorTechnology
- IndustryLaboratory Analytical Instruments
- HeadquartersLexington, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.30.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2021 | 50 |
| Q4 2021 | 56 |
| Q1 2022 | 60 |
| Q2 2022 | 53 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2021 | 33 | 17 |
| Q1 2022 | 34 | 22 |
| Q2 2022 | 24 | 37 |
Biggest buyers
| KENNEDY LEWIS MANAGEMENT LP | Added | +3.1m |
| INDUSTRY VENTURES, L.L.C. | New | +287.5k |
| Arena Investors LP | New | +235.0k |
| Oasis Management Co Ltd. | New | +187.6k |
| MILLENNIUM MANAGEMENT LLC | New | +109.1k |
| HAMILTON LANE ADVISORS LLC | New | +97.9k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | +91.8k |
| GLENVIEW CAPITAL MANAGEMENT, LLC | Added | +84.2k |
| Ergoteles LLC | New | +70.4k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Added | +50.0k |
Biggest sellers
| D1 Capital Partners L.P. | Sold out | -2.6m |
| BlackRock Inc. | Reduced | -592.0k |
| STATE STREET CORP | Reduced | -395.3k |
| VANGUARD GROUP INC | Reduced | -277.1k |
| PERCEPTIVE ADVISORS LLC | Sold out | -190.7k |
| JPMORGAN CHASE & CO | Reduced | -159.7k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -134.6k |
| Woodline Partners LP | Sold out | -130.6k |
| NORTHERN TRUST CORP | Reduced | -109.1k |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Sold out | -94.2k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Bain Capital Life Sciences Fund, L.P. 13G · exempt (held before listing) filed 2026-08-14 | 16.8% |
| Longitude Capital Partners II, LLC 13G · exempt (held before listing) filed 2026-05-15 | 8.6% |
| ARMISTICE CAPITAL, LLC 13G · institution new · filed 2026-08-14 | 7.3% |
Spignesi Robert G. Jr.
13D · may seek influence
new · filed 2025-08-19
Stated purposeThe information set forth or incorporated by reference in Items 3 and 6 of this Statement is incorporated by reference into this Item 4. The Reporting Person intends to continuously review his investment in the Issuer and may in the future determine (1) to acquire additional securities of the Issuer, through open market purchases, private agreements or otherwise, (2) to dispose of all or a portion of the securities of the Issuer owned by him or (3) to take any other available course of action. Notwithstanding anything contained herein, the Reporting Person specifically reserves the right to change his intention with respect to any or all of such matters. In reaching any decision as to his course of action (as well as to the specific elements thereof), the Reporting Person currently expect… Full filing |
6.3% |
| Endeavour Medtech Growth II LP 13G · passive investor filed 2026-02-13 | 5.7% |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 1 | $2.0m | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 1 | $69.5k | 0 | — | — |
| Q2 2022 | 1 | $38.0k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2022-06-03 | Richman Darren +9 10% owner · See Footnotes | Bought | $233.0k50.0k shares |
| 2022-06-02 | Richman Darren +9 10% owner · See Footnotes | Bought | $50.4k10.1k shares |
| 2022-06-01 | Richman Darren +9 10% owner · See Footnotes | Bought | $224.3k47.1k shares |
| 2022-05-31 | Richman Darren +9 10% owner · See Footnotes | Bought | $102.2k20.0k shares |
| 2022-05-27 | Richman Darren +9 10% owner · See Footnotes | Bought | $7.9k1.5k shares |
| 2022-05-26 | Richman Darren +9 10% owner · See Footnotes | Bought | $103.3k21.1k shares |
| 2022-05-25 | Richman Darren +9 10% owner · See Footnotes | Bought | $125.6k28.8k shares |
| 2022-05-18 | Richman Darren +9 10% owner · See Footnotes | Bought | $106.4k27.0k shares |
| 2022-05-17 | Richman Darren +9 10% owner · See Footnotes | Bought | $287.1k69.5k shares |
| 2022-05-16 | Spignesi Robert G. Jr. President and CEO, director | Bought | $38.0k10.0k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC 4.25% of their portfolio | 8.4m $36.3m | Unchanged |
| KENNEDY LEWIS MANAGEMENT LP 23.35% of their portfolio | 4.9m $21.2m | Added +3.1m |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 3.4m $14.7m | Reduced -20.0k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 1.5m $6.4m | Reduced -159.7k |
| BlackRock Inc. 0.00% of their portfolio | 1.0m $4.5m | Reduced -592.0k |
| ABG-WTT Global Life Science Capital Partners GP Ltd 15.75% of their portfolio | 1.0m $4.5m | Unchanged |
| GLENVIEW CAPITAL MANAGEMENT, LLC 0.08% of their portfolio | 750.0k $3.2m | Added +84.2k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.01% of their portfolio | 750.0k $3.2m | Added +50.0k |
| Ally Bridge Group (NY) LLC 2.74% of their portfolio | 699.7k $3.0m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 679.8k $2.9m | Reduced -277.1k |
| Advent International, L.P. 0.02% of their portfolio | 577.8k $2.5m | Unchanged |
| Rhenman & Partners Asset Management AB 0.15% of their portfolio | 300.0k $1.3m | Unchanged |
| INDUSTRY VENTURES, L.L.C. 1.31% of their portfolio | 287.5k $1.2m | New |
| Arena Investors LP 0.47% of their portfolio | 235.0k $1.0m | New |
| Oasis Management Co Ltd. 0.15% of their portfolio | 187.6k $807.0k | New |
| TD Asset Management Inc 0.00% of their portfolio | 133.8k $575.0k | Unchanged |
| FRED ALGER MANAGEMENT, LLC 0.00% of their portfolio | 123.8k $532.0k | Reduced -2.5k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 109.1k $469.0k | New |
| HAMILTON LANE ADVISORS LLC 0.16% of their portfolio | 97.9k $421.0k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 92.5k $397.0k | Reduced -134.6k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 91.8k $395.0k | New |
| Ergoteles LLC 0.01% of their portfolio | 70.4k $303.0k | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 53.5k $230.0k | Added +22.5k |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio | 52.9k $168.7k | Unchanged |
| AMERIPRISE FINANCIAL INC 0.00% of their portfolio | 50.9k $219.0k | Reduced -349 |
| TPG GP A, LLC 0.00% of their portfolio | 47.9k $206.0k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 34.8k $151.0k | Added +9.9k |
| Bank of New York Mellon Corp 0.00% of their portfolio | 30.0k $129.0k | Reduced -33.2k |
| GSA CAPITAL PARTNERS LLP 0.02% of their portfolio | 29.8k $128.0k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 29.7k $128.0k | New |
| Magnetar Financial LLC 0.00% of their portfolio | 28.9k $124.0k | Reduced -12.2k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 28.5k $123.0k | New |
| CAAS CAPITAL MANAGEMENT LP 0.02% of their portfolio | 27.8k $119.0k | Unchanged |
| STATE STREET CORP 0.00% of their portfolio | 26.1k $112.0k | Reduced -395.3k |
| Parkwood LLC 0.02% of their portfolio | 24.5k $105.0k | Unchanged |
| NORTHERN TRUST CORP 0.00% of their portfolio | 21.3k $92.0k | Reduced -109.1k |
| BOOTHBAY FUND MANAGEMENT, LLC 0.00% of their portfolio | 18.7k $81.0k | New |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 13.1k $56.0k | New |
| Schonfeld Strategic Advisors LLC 0.00% of their portfolio | 10.0k $43.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 9.7k $42.0k | Added +8.2k |
| CITIGROUP INC 0.00% of their portfolio | 9.4k $41.0k | Added +8.1k |
| UBS Group AG 0.00% of their portfolio | 4.6k $20.0k | Reduced -316 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 2.0k $8.0k | Reduced -4.3k |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 778 $3.0k | Added +650 |
| Sterling Investment Advisors, Ltd. 0.00% of their portfolio | 654 $3.0k | New |
| RESOURCES MANAGEMENT CORP /CT/ /ADV 0.00% of their portfolio | 500 $2.0k | Unchanged |
| FMR LLC 0.00% of their portfolio | 289 $1.0k | Reduced -795 |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 150 $1.0k | Reduced -5.9k |
| Daiwa Securities Group Inc. 0.00% of their portfolio | 101 $0 | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 58 $0 | Reduced -2.9k |
| Ellevest, Inc. 0.00% of their portfolio | 10 $0 | New |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 8 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |